Entegris, Inc.

ENTG

CIK 0001101302 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$824M
↓-3.0% -$26Mvs FY2024 (Q4)
Operating Income
$105M
↓-30.0% -$45Mvs FY2024 (Q4)
Net Income
$49M
↓-51.7% -$53Mvs FY2024 (Q4)
Gross Profit
$361M
↓-6.9% -$27Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
32/100
  • Profitability
    3ROIC 5.5% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 3.35 (above 1.5 = solid)
  • Leverage
    53D/E 0.94 (under 0.5 = conservative)
  • Efficiency
    14Asset Turnover 0.38x (1.0+ = capital-efficient)
  • Growth
    7Revenue YoY -3.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    14Op Margin 12.7% · trend -2.2pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project ENTG's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$44.78
Total enterprise IV
$6.82B
Diluted shares
0.15B
Terminal PV
$4.94B (72% of total)
Year-5 FCF
$582M
YearProjected FCFDiscounted PV
+1$428M$389M
+2$462M$382M
+3$499M$375M
+4$539M$368M
+5$582M$361M
Terminal$7.96B$4.94B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$299M
investment in PP&E
Dividends paid (TTM)
$61M
cash returned to holders
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
$69M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$8.35B
everything owned
Stockholders' equity
$3.95B
shareholder claim
Net debt
$3.34B
LT debt minus cash

Recent performance · 64 quarters

Revenue↓-3.0% -$26M
$824M
Net Income↓-51.7% -$53M
$49M
Free Cash Flow↑+95.4% +$65M
$134M
Operating Margin↓-4.9pts
12.7%

Drill down